Joshua Armenia is a Senior Scientist at AstraZeneca where he works in the Oncology Bioinformatics group and his main focus is the DNA damage response portfolio. Previously Josh worked at Memorial Sloan Kettering (New York) in Niki Schultz’s lab for 4 years where he led the genomic characterization of a large exome-sequencing prostate cancer cohort in collaboration with Eli Van Allen’s group at Dana Farber. The results of this project were recently published in Nature Genetics (PMID 29610475). Josh was also a co-leader of the TCGA PANCAN Pathway project where he and others investigated oncogenic signalling pathways across 9,125 tumors profiled by The Cancer Genome Atlas (TCGA). The results of this effort were published on Cell (PMID 29625050).